MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Hypermethylation of PGC-1α in peripheral blood leukocytes of patients with Parkinson’s disease

    X. Yang, SQ. Xu, W. Qian, Q. Xiao (Shanghai, China)

    Objective: We aimed to explore the hypothesis that the PGC-1α variants are associated with its promoter methylations level thus affecting the PGC-1α mRNA expression. We…
  • 2019 International Congress

    NS-PARK cohort: a nationwide real life longitudinal cohort of PD patients

    H. Alfaisal, F. Durif, S. Thobois, L. Defebvre, JP. Azulay, P. Couratier, P. Damier, D. Devos, S. Drapier, A. Doe Demaindreville, S. Frismand, C. Geny, C. Giordana, JL. Houeto, P. Krystkowiak, E. Magnin, D. Maltête, W. Meissner, C. Moreau, E. Moro, P. Remy, C. Thiriez, C. Tranchant, F. Viallet, M. Vidailhet, E. Dellapina, V. Chaigneau, C. Dongmo, F. Tubach, Y. de Rycke, O. Rascol, JC. Corvol (Paris, France)

    Objective: To describe the Parkinson disease (PD) population followed by the 25 expert centers for PD in France. Background: NS-PARK is the clinical research network…
  • 2019 International Congress

    Longitudinal analysis of the relation between trajectories of dopaminergic agonists use and BMI in Parkinson’s disease

    F. Artaud, PC. Lee, M. Vidailhet, JC. Corvol, A. Elbaz (Saint-Aubin, France)

    Objective: To describe the longitudinal relation between dopaminergic agonists (DA) use and change of BMI in a longitudinal cohort of PD patients followed annually up…
  • 2019 International Congress

    Self-reported demographic, genetic, symptom, and treatment data of subjects in the Fox Trial Finder

    M. Bailey, A. Gera, Y. Liu, B. Ouyang, G. Pal (Chicago, IL, USA)

    Objective: To examine the characteristics of subjects within the Fox Trial Finder (FTF) database. Background: FTF is an online, patient driven database by which Parkinson’s…
  • 2019 International Congress

    Advanced Stage of Parkinson’s Disease: From Identification to Characterization and Disease Burden Assessment Using a Nationwide Database

    Y. Barer, T. Gurevich, G. Chodick, N. Giladi, R. Gross, R. Cohen, L. Bergmann, Y. Jalundhwala, V. Shalev, A. Thaler (Tel Aviv-Yafo, Israel)

    Objective: To identify and describe PD patients who were prescribed intensified therapy and compare their burden of disease with mild-moderate PD patients. Background: Real-world data…
  • 2019 International Congress

    Movement disorders in neurologic consultation of Marrakesh University Hospital

    L. Berrhoute, J. El Mesbahy, N. Kissani (Marrakesh, Morocco)

    Objective: Describing the epidemiological and clinical aspects of the movement’s disorders in Marrakesh. Analyzing difficulties of management of this disease. Comparing our data with international…
  • 2019 International Congress

    Establishing the first apomorphine treatment registry in Thailand: prospective data collection to inform optimal care of Parkinson’s disease patients

    R. Bhidayasiri, O. Phokaewvarangkul, K. Boonpang, T. Boonmongkol, Y. Thongchuam, N. Kantachadvanich, J. Sringean, P. Panyakaew, P. Jagota (Bangkok, Thailand)

    Objective: To establish a registry of PD patients in Thailand treated with subcutaneous apomorphine (APO) injection or infusion to allow prospective data collection from the…
  • 2019 International Congress

    Clinical profile of idiopathic Parkinson’s disease in patients admitted to Mohamed VI University Hospital center of Marrakech

    A. Boudanga, N. Jalami, M. Chraa, N. Kissani (Marrakech, Morocco)

    Objective: Prevalence studies in different parts of the world have shown that Parkinson's disease is a pathology that has a very important impact in older…
  • 2019 International Congress

    Association of active and passive smoking with Parkinson’s disease in women: the E3N cohort study

    M. Canonico, F. Artaud, D. Cerasuolo, I. Degaey, P. Gerbouin-Rerolle, A. Kowal, E. Roze, G. Severi, MC. Boutron-Ruault, A. Elbaz (Villejuif, France)

    Objective: To investigate the association of active and passive smoking with Parkinson’s disease (PD) incidence in women over 25y of follow-up. Background: PD is the…
  • 2019 International Congress

    Can Safinamide Help to Stabilize Dopaminergic Treatment in Parkinson’s Disease?

    B. Solano Vila, A. Cots Foraster, M. Montserrat Roses (Girona, Spain)

    Objective: After more than two years of clinical experience with safinamide  we want to retrospectively review its utility as a levodopa saver in our Parkinson's…
  • « Previous Page
  • 1
  • …
  • 1151
  • 1152
  • 1153
  • 1154
  • 1155
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley